Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Efavirenz 400mg in Pregnant HIV+ Women
NCT02499874Phase 1Completed
- Sponsor
- St Stephen's AIDS Trust
- Start
- Aug 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of efavirenz in human immunodeficiency virus infection (HIV), sponsored by St Stephen's AIDS Trust. Primary endpoints: Trough Concentration and Area Under the Curve. Started Aug 2015; status: completed.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02499874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02499874.